Medpace Holdings, Inc. revenue breakdown overview

Medpace Holdings, Inc. revenue for the last year amounted to 2.11 B USD, the most of which — 651.24 M USD — came from its highest performing source at the moment, Oncology, the year earlier bringing 587.10 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Medpace Holdings, Inc. 2.07 B USD, and the year before that — 1.85 B USD.